Another important mechanism of action of YS110 was the nuclear translocation of CD26 molecules by internalization of the CD26-YS110 complexes from the cell surface to inhibit proliferation of MM cells via suppression of POLR2A gene expression, a component of RNA polymerase II. The gene discussed is DPP4; the disease is Miyoshi myopathy.